bietamiverine
This page covers all bietamiverine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Muscarinic acetylcholine receptor M1, Muscarinic acetylcholine receptor M2, Muscarinic acetylcholine receptor M3.
Targets
Phase 2 pipeline (1)
- Paparid · Other
Paparid works by blocking the M3 receptor, which helps to reduce smooth muscle contraction and glandular secretion.
Patent intelligence
- bietamiverine patent landscape — aggregated cliff calendar, attackable patents, originator estates